Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
BridgeBio Pharma Announces Launch of Secondary Offering of Common Stock on Behalf of an Existing Shareholder
GlobeNewswire, Inc.
PALO ALTO, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for genetic conditions, announced today the...
World Pet Association Launches petLENS to Deliver Continuous Pet Industry Intelligence
EIN Presswire
Developed with BSM Partners, petLENS gives the pet industry ongoing access to consumer research and expert analysis to guide decisions throughout the year LAS VEGAS, NV, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- World Pet Association...
Gemologists Use Scientific Methods and Established Standards to Evaluate Diamonds and Precious Stones
EIN Presswire
METAIRIE, LA, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- Evaluating diamonds and precious stones involves considerably more than examining whether a gemstone appears attractive under a display light.
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
GlobeNewswire, Inc.
TORONTO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the...
Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
GlobeNewswire, Inc.
SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”), a clinical oncology innovator advancing late-stage development of an investigational, potentially first-in-class WEE1...
Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire, Inc.
Total net revenue increased 14% to $18.7 million for second quarter of 2026 compared to second quarter of 2025 Partnered programs continue to advance with Crystalys Therapeutics announcing its $130 million Series B financing to support the...
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
$26.2 million in U.S. neffy® net product revenue in Q2 2026; total U.S. epinephrine market share for Type 1 allergies of 5% and 8% share within field-targeted accounts Commercial investment realigned toward targeted provider engagement,...
Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Successful End-of-Phase 2 meeting with FDA supports advancement of tegoprubart into a global Phase 3 kidney transplantation trial, on track to initiate in late 2026 Long-term Phase 2 BESTOW data presented at ATC 2026 demonstrated sustained higher...
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
All participants successfully dosed in SLIM-1™, the Company's first-in-human Phase 1 trial of NPM-139, a miniature, ultra long-acting semaglutide implant for chronic weight management; top-line data expected in November 2026 Company entered into...
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
Record revenue, with Q2 2026 product sales of $37.6 million, representing 99% growth over Q2 2025 Q2 2026 fully diluted GAAP EPS of $0.35, non-GAAP fully diluted EPS of $0.43; EBITDA of $14.1 million, Adjusted EBITDA of $16.2 million Raising full...
The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
GlobeNewswire, Inc.
DENVER, Aug. 13, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings’ (NASDAQ: NTHI) August 12 headline was impossible to miss, but another interesting solution may be hiding in plain sight: while NeOnc produced encouraging data for one cancer...
Life Science Tools Market Outlook Highlights Strategic Opportunities Across The Industry
EIN Presswire
The Business Research Company’s Life Science Tools Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, August 13, 2026 /EINPresswire.com/ -- The life science tools market is...
Life Science And Chemical Instrumentation Market Insights Highlight Segment Expansion And Market Leadership
EIN Presswire
The Business Research Company’s Life Science And Chemical Instrumentation Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, August 13, 2026 /EINPresswire.com/ -- The life science and...
DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
GlobeNewswire, Inc.
BROSSARD, Quebec, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI)...
Nature Provides Film on Plant Stem Cell Science Wins Best Documentary at Dreamz Catcher International Film Festival
EIN Presswire
Episode 2, Exploring the Science of Embryonic Plant Stem Cells, Earns Its First Wave of International Recognition for Jennifer and Louis Payeur.
Auction Alert: Be Biopharma online auction to feature over 600 lots of high-end R&D and biotech instruments
EIN Presswire
The Be Biopharma online auction opens August 18th at 10AM PST CAMBRIDGE, MA, UNITED STATES, August 13, 2026 /EINPresswire.com/ -- Silicon Valley Disposition (SVD) will be conducting an online auction for the assets of Be Biopharma.
Ikon Science unites Petrosys Group and Omnira Software under the Ikon Science brand
EIN Presswire
Three Trusted Names.
Laboratory Accessories Market Study Highlights How Industry Demand Is Evolving
EIN Presswire
The Business Research Company's Laboratory Accessories Market Study Highlights How Industry Demand Is Evolving LONDON, GREATER LONDON, UNITED KINGDOM, August 13, 2026 /EINPresswire.com/ -- "The laboratory accessories market has been experiencing...
MLM Medical Labs and Amprion Announce Strategic Collaboration to Expand Access to α-Synuclein Testing in Europe
EIN Presswire
MLM and Amprion partner to expand access to breakthrough α-synuclein biomarker testing for European neurodegenerative clinical trials.
PDS Biotech Reports Second Quarter 2026 Financial Results
GlobeNewswire, Inc.
PRINCETON, N.J., Aug. 13, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage biotechnology company focused on developing targeted immunotherapies for cancer, today provided a...
Sign up for:
Technology News Journal
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.